How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

539 results for

Postpartum Endometritis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

381. Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients

, reduce the frequency of pregnancy continuing beyond 41 or 42 weeks, and reduce the frequency of formal induction of labor. Thus, it is a safe and practical option for women who wish to avoid inductions of labor or postterm pregnancies. Group B streptococcus (GBS; streptococcus agalactiae) is a gram positive coccus that frequently colonizes the human genital tract. In pregnant women, GBS can cause urinary tract infections, chorioamnionitis, and postpartum endometritis. Newborn infants can also acquire (...) in Group B Streptococcus (GBS) Positive Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01180023 Recruitment Status : Completed First Posted : August 11, 2010 Last Update Posted : February 15, 2013 Sponsor: George Washington University Information provided by (Responsible Party): Jennifer

2010 Clinical Trials

382. Postplacental Mirena IUD Insertion and Estimating Expulsion Rates.

standard for IUD insertion postpartum. Secondary outcomes will also be examined; endometritis, uterine perforation, continuation and pregnancy among others. Condition or disease Intervention/treatment Phase Estimating Rates of Expulsion Device: Levonorgestrel Intrauterine Device Phase 4 Detailed Description: The average expulsion rate for 6 week postpartum IUD insertion is approximately 10-12% with a range between 3-20% at 1 year. An acceptable expulsion rate for postplacental insertion (PPI) has (...) weeks postpartum ] Secondary Outcome Measures : breastfeeding [ Time Frame: 12 weeks ] request for IUD removal [ Time Frame: 12 weeks ] endometritis [ Time Frame: 12 weeks ] uterine perforation [ Time Frame: 12 weeks ] pregnancy [ Time Frame: 12 weeks ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about

2010 Clinical Trials

383. LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

should be postponed until the uterus is fully involuted, and not earlier than 6 weeks after delivery. If involution is substantially delayed, the investigator should consider waiting until 12 weeks postpartum. Infected abortion or postpartum endometritis within 3 months prior to the Screening Visit (Visit 1) Chronic, daily use of drugs that may increase serum potassium levels, such as nonsteroidal anti-inflammatory drugs (NSAIDs, eg. ibuprofen and naproxen), potassium-sparing diuretics (eg (...) Contraceptive (COC) User Satisfaction Study The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01254292 Recruitment Status : Completed First Posted : December 6, 2010 Results First Posted : April 7, 2014 Last Update Posted : September 25, 2017 Sponsor: Bayer Information provided by (Responsible Party): Bayer

2010 Clinical Trials

384. Does Vitamins C and E Supplementation of After Preterm Rupture of Membranes Prolong the Duration of Latency? A Prospective Randomized Controlled Study

delivery Secondary Outcome Measures : postpartum endometritis rate, early onset neonatal sepsis rate, [ Time Frame: days ] Other outcomes were the birth weight, mode of delivery, occurrence of clinical chorioamnionitis, postpartum endometritis, early onset neonatal sepsis, grade 3-4 intraventricular haemorrhage (IVH), stage 2-3 necrotizing enterocolitis (NEC), admission to intensive care unit (ICU), duration of stay in an intensive care unit and respiratory distress syndrome. Eligibility Criteria Go (...) for details. ClinicalTrials.gov Identifier: NCT01266928 Recruitment Status : Completed First Posted : December 24, 2010 Last Update Posted : February 7, 2012 Sponsor: Erzincan Military Hospital Information provided by (Responsible Party): Kemal GUNGORDUK, Erzincan Military Hospital Study Details Study Description Go to Brief Summary: Preterm premature rupture of membranes (PPROM) is a complication affecting 3-4.5% of all pregnancies. PPROM is the main known cause of preterm delivery and is associated

2010 Clinical Trials

385. A Pilot Study of Early Postpartum Intrauterine Contraception

A Pilot Study of Early Postpartum Intrauterine Contraception A Pilot Study of Early Postpartum Intrauterine Contraception - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Pilot Study of Early Postpartum (...) Intrauterine Contraception (ImmPPIUD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00997932 Recruitment Status : Completed First Posted : October 20, 2009 Results First Posted : March 29, 2017 Last Update Posted : March 29, 2017 Sponsor: University of North Carolina, Chapel Hill Information provided

2009 Clinical Trials

386. Mirena in Idiopathic Menorrhagia

to international guidelines. These woman should also accept to be on contraception during the time period that they have Mirena in situ. Age limit 30-45 BMI= 18-34 Signed informed consent Exclusion Criteria: Medical conditions featured in the Mirena data sheet (See Appendix 1) that contraindicate its use, listed below: Known or suspected pregnancy; current or recurrent pelvic inflammatory disease; infection of the lower genital tract; postpartum endometritis; septic abortion during the past three months (...) is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00868153 Recruitment Status : Completed First Posted : March 24, 2009 Last Update Posted : February 18, 2015 Sponsor: Bayer Information provided by (Responsible Party): Bayer Study Details Study Description Go to Brief Summary: This is an open-label, uncontrolled, multi-centre observational study that analyses

2009 Clinical Trials

387. Comparison of Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Intrapartum Chorioamnionitis: a Randomized Controlled Trial

intravenous normal saline placebo dose every 8 hours until 24 hours post delivery. Active Comparator: Ampicillin/gentamicin Drug: Ampicillin/gentamicin Gentamicin 1.5mg/kg intravenously every 8 hours plus ampicillin 2 grams intravenously every 6 hours until 24 hours post delivery. Outcome Measures Go to Primary Outcome Measures : Treatment Success Defined as Resolution of Fever by 24 Hours Postpartum [ Time Frame: Up to 24 hours after delivery ] Proportion of patients in each arm experiencing treatment (...) success defined as resolution of fever by 24 hours postpartum Secondary Outcome Measures : Composite Maternal Morbidity [ Time Frame: Up to 6 weeks after delivery ] Composite of maternal postpartum morbidity defined as any of the following outcomes: endometritis, clinical sepsis, pneumonia, blood transfusion or ileus. Neonatal Clinical Sepsis (Early Onset) [ Time Frame: Up to 6 weeks after delivery ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate

2009 Clinical Trials

388. Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

three months according to the assessment of the investigator and according to the international and national guidelines. These women should also accept to be on contraception during the time period that they have Mirena in situ Body Mass Index = 18-30 Exclusion Criteria: One or more of the following disorders: Current or recurrent pelvic inflammatory disease; infection of the lower genital tract; postpartum endometritis; septic abortion during the past three months; cervicitis; cervical dysplasia (...) . Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00874653 Recruitment Status : Completed First Posted : April 2, 2009 Last Update Posted : June 23, 2014 Sponsor: Bayer Information provided by (Responsible Party): Bayer Study

2009 Clinical Trials

389. GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

. GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00884260 Recruitment Status : Completed First Posted : April 20, 2009 Last Update Posted : August 21, 2014 Sponsor: Bayer Information provided by (Responsible Party (...) : Postpartum insertions should be postponed until uterus is fully involuted, however not earlier than 6 weeks after delivery. If involution is substantially delayed, consider waiting until 12 weeks postpartum. In case of a difficult insertion and/or exceptional pain or bleeding during or after insertion, physical examination and ultrasound should be performed immediately to exclude perforation. History of ectopic pregnancies. Note: For Korea only: History of ectopic pregnancies or high probability

2009 Clinical Trials

390. Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine

adding more. Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00858832 Recruitment Status : Completed First Posted : March 10, 2009 Results First Posted : September 19, 2012 Last Update Posted : September 19, 2012 (...) received Methergine 0.2mg po every 6 hours for two days, plus routine postpartum care. Drug: Methergine Scheduled methergine 0.2 mg PO every 6hrs for duration of postpartum stay No Intervention: No treatment No treatment group received only routine postpartum care. Outcome Measures Go to Primary Outcome Measures : Endometritis Incidence [ Time Frame: One year ] Number of participants who developed endometritis Eligibility Criteria Go to Information from the National Library of Medicine Choosing

2009 Clinical Trials

391. Pleiotropic effects of negative energy balance in the postpartum dairy cow on splenic gene expression: repercussions for innate and adaptive immunity Full Text available with Trip Pro

global gene expression in the spleen of dairy cows in the early postpartum period. Spleen tissue was removed post mortem from five severe NEB (SNEB) and five medium NEB (MNEB) cows 15 days postpartum. SNEB increased systemic concentrations of NEFA and BHB, and white blood cell and lymphocyte numbers were decreased in SNEB animals. A total of 545 genes were altered by SNEB. Network analysis using Ingenuity Pathway Analysis revealed that SNEB was associated with NRF2-mediated oxidative stress (...) Pleiotropic effects of negative energy balance in the postpartum dairy cow on splenic gene expression: repercussions for innate and adaptive immunity Increased energy demands to support lactation, coupled with lowered feed intake capacity results in negative energy balance (NEB) and is typically characterized by extensive mobilization of body energy reserves in the early postpartum dairy cow. The catabolism of stored lipid leads to an increase in the systemic concentrations of nonesterified

2009 Physiological genomics

392. Efficacy of homeopathic remedies as prophylaxis of bovine endometritis. Full Text available with Trip Pro

Efficacy of homeopathic remedies as prophylaxis of bovine endometritis. The objective of this study was to evaluate the efficacy of 2 different homeopathic prophylactic strategies for the prevention of endometritis. The drugs used were Lachesis compositum (Lachesis), Carduus compositum (Carduus), and Traumeel LT (Traumeel). Each drug contained a mixed formula of homeopathic remedies. All 929 cows received the first treatment within 24 h postpartum. The second to fourth treatments were conducted (...) at 7 to 13, 14 to 20, and 21 to 27 d in milk, respectively. In the first group, the 4 treatments were Traumeel, Lachesis, Carduus, and Carduus, respectively (n = 206). In the second group, Lachesis was administered 3 times, followed by 1 treatment with Carduus (n = 198). The control group received 4 injections of saline (n = 189). In the fourth week after calving, the prevalence of clinical endometritis, uterine involution, and ovarian activity was monitored by rectal palpation

2009 Journal of dairy science Controlled trial quality: uncertain

393. Perioperative Antibiotic Prophylaxis for Nonlaboring Cesarean Delivery. Full Text available with Trip Pro

for reasons other than prophylaxis. The occurrence of postpartum endometritis, wound infection, and other, less common infection-related complications was compared between those who did and did not receive antibiotic prophylaxis. Results were adjusted for smoking, payer status, gestational age and body mass index at delivery, race, diabetes, antepartum infections, presence of anemia, operative time, type of cesarean delivery (primary or repeat), and center.Of the 9,432 women who met study criteria (...) , the 6,006 (64%) who received antibiotic prophylaxis were younger, heavier at delivery, and were more likely to be African American, receive public insurance, and have diabetes. Patients who received antibiotic prophylaxis were less likely to develop postpartum endometritis (121 [2.0%] compared with 88 [2.6%], adjusted odds ratio [OR] 0.40, 95% confidence interval [CI] 0.28-0.59) or wound infection (31 [0.52%] compared with 33 [0.96%], adjusted OR 0.49, 95% CI 0.28-0.86).Antibiotic prophylaxis

2009 Obstetrics and Gynecology

394. Antimicrobial prophylaxis for cesarean delivery before skin incision. (Abstract)

had lower rates of postpartum endometritis (2.2% compared with 3.9%) and wound infection (2.5% compared with 3.6%). After multivariable logistic regression, antimicrobial prophylaxis before skin incision remained associated with lower rates of endometritis (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.47-0.79) and wound infection (OR 0.70, 95% CI 0.55-0.90). Antimicrobial prophylaxis before skin incision had no adverse effect on neonatal infection rates or on the evaluation

2009 Obstetrics and Gynecology

395. An unusual cause of delayed postpartum haemorrhage following caesarean section. (Abstract)

An unusual cause of delayed postpartum haemorrhage following caesarean section. Although less common in the UK, postpartum haemorrhage (PPH)--defined as blood loss of 500 ml or more within the first 24 h of delivery--remains a significant cause of maternal death worldwide. Haemorrhage between 24 h and 6 weeks post partum is termed "delayed PPH". Common causes include retention of gestational products or endometritis. Bleeding can be sudden and profound, resulting in rapid cardiovascular

2009 Emergency Medicine Journal

396. Effect of source of supplemental selenium on uterine health and embryo quality in high-producing dairy cows. (Abstract)

blastomeres, or proportions of grades 1 and 2, degenerated, and degenerated-unfertilized embryos/oocytes. Odds of subclinical endometritis on Day 30 postpartum more than doubled in cows with fever of unknown origin or acute puerperal metritis in the first 10 DIM. Fertilization rate tended to be reduced in cows with subclinical endometritis. In summary, replacing SS with an organic source of Se in diets not suboptimal in basal Se concentrations did not improve Se status, uterine health, fertilization (...) uterine horn was assessed at 30 DIM. The Ovsynch protocol was initiated at 42 DIM; ovarian responses to hormonal treatments were evaluated by ultrasonography. The uteri of cows were flushed 6d after timed AI for collection of embryos and oocytes. Plasma concentrations of Se and progesterone were measured throughout the postpartum period and during the reproductive protocol, respectively, and plasma glutathione peroxidase activity was determined 6d after AI. Concentrations of Se in pre- and postpartum

2009 Theriogenology Controlled trial quality: uncertain

397. Iodine

diabetic and other external ulcers. Iodine is also applied inside the mouth to treat gum disease (periodontitis) and reduce bleeding after the removal of a tooth. Iodine can also be used as a throat rinse to reduce symptoms of pneumonia. Iodine is used in the eyes to reduce swelling in infants and to prevent vision loss in patients with ulcers of the cornea. Iodine is used in the vagina to prevent post-Cesarean swelling of the lining of the uterus. Iodine is injected into a portion of the pelvis (...) for people with foot ulcers related to diabetes. Inflammation of the uterus (endometritis) . Washing the vagina with a solution containing iodine in the form of povidone-iodine before a Cesarean delivery reduces the risk of the inflammation of the uterus. Painful fibrous breast tissue (fibrocystic breast disease) . Research shows that taking iodine, especially molecular iodine, reduces painful fibrous breast tissue. Breast pain (mastalgia) . Taking 3000-6000 mg of molecular iodine for 5 months seems

2009 National Centre for Complementary and Alternative Medicine

398. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. (Abstract)

contacted to locate any other studies. The search strategy was iterative.Randomized clinical trials assessing the efficacy and safety of ECS for prevention of MTCT of HIV-1 were included in the analysis, as were observational studies with relevant data.Data regarding HIV-1 infection status of infants born to HIV-1-infected women according to mode of delivery were extracted from the reports of the studies. Similarly, data regarding postpartum morbidity (PPM) (including minor (e.g., febrile morbidity (...) , urinary tract infection) and major (e.g., endometritis, thromboembolism) morbidity) of the HIV-1-infected women, and infant morbidity, according to mode of delivery were extracted.One randomized clinical trial of the efficacy of ECS for prevention of MTCT of HIV-1 was identified. No data regarding infant morbidity according to the HIV-1-infected mother's mode of delivery were available. Data regarding PPM according to mode of delivery were available from this clinical trial as well as from five

2005 Cochrane

399. Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. (Abstract)

Prophylactic antibiotics for manual removal of retained placenta in vaginal birth. Retained placenta is a potentially life-threatening condition because of its association with postpartum haemorrhage. Manual removal of placenta increases the likelihood of bacterial contamination in the uterine cavity.To compare the effectiveness and side-effects of routine antibiotic use for manual removal of placenta in vaginal birth in women who received antibiotic prophylaxis and those who did (...) not and to identify the appropriate regimen of antibiotic prophylaxis for this procedure.We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 November 2005), CENTRAL (The Cochrane Library, Issue 4, 2005), MEDLINE (from 1966 to January 2005), EMBASE (from 1980 to January 2005), CINAHL (from 1982 to January 2005) and LILACS (from 1982 to January 2005).All randomized controlled trials comparing antibiotic prophylaxis and placebo or non antibiotic use to prevent endometritis after manual

2006 Cochrane

400. Fetal pulse oximetry for fetal assessment in labour. Full Text available with Trip Pro

0.45, 95% CI 0.28 to 0.72). The only reported neonatal seizure occurred in the CTG only group (RR 0.29 95% CI 0.01 to 7.08). Use of FPO with CTG decreased operative delivery (caesarean section, forceps, vacuum) for nonreassuring fetal status (RR 0.71, 95% CI 0.55 to 0.93) compared with CTG alone. No differences were seen for overall operative deliveries, endometritis, intrapartum or postpartum haemorrhage, uterine rupture, low Apgar scores, umbilical arterial pH or base excess, admission

2004 Cochrane

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>